dihexa half-life 12 days Synapse (Dihexa) Cognitive Peptide Therapy Lincoln Park Journal of Prescribing Practice -

Side Effects and Safety Considerations BPC-157 demonstrates an excellent safety profile across decades of animal research and extensive community use

Vomiting odds increased dramatically with an odds ratio of 9.57 compared to placebo

Schwann cells are the support cells responsible for myelinating peripheral nerve fibers, and their shift to a repair phenotype after nerve injury is essential for regeneration

NAD (Nicotinamide Adenine Nucleotide) NAD was first described in 1906 by Harden and Young as a cell component that enhanced alcohol fermentation (Harden and Young, 1906)

Pramlintide was approved by the FDA in 2005 for the treatment of type 1 diabetes mellitus and insulin-requiring type 2 diabetes, and was also explored as a novel anti-obesity treatment